Acquiring Company
Veristat
Acquired Company
Scinopsis
SouthboroughBiotechnologyHealth CareTherapeuticsBiotechnologyHealth CareDescription
Veristat, a scientific-minded global clinical research organization (CRO), has acquired Scinopsis, a European medical writing consultancy with a 17-year track record of delivering regulatory and medical communication documents of the highest quality to the biopharmaceutical industry. The acquisition strengthens Veristat’s ability to meet growing client demand in one of its highest-valued service areas as the range of clinical trial content expands and the importance of regulatory documentation increases.
Quick answer
Veristat is acquiring Scinopsis, announced June 12, 2023. Veristat is based in Southborough, Massachusetts, United States.
- How much did Veristat pay for Scinopsis?
- The deal value was not disclosed.
- What does Veristat do?
- Veristat is the science-first full-service drug and biologic CRO and consultancy that integrates strategic planning, regulatory expertise, and clinical trial execution to rapidly advance the most complex or novel..
- Where are Veristat and Scinopsis based?
- Veristat is based in Southborough, Massachusetts, United States.
- Who are the decision-makers at Veristat?
- Fundz holds 1 contact at Veristat. Names and contact details are shown to Fundz members.
Source: Fundz verified event record.
Other recent acquisitions in Therapeutics and Biotechnology
Deals where the buyer or target shares a sector with this one, within 45 days, from Fundz verified event records.
- Dtx Pharma Announces Acquisition By Novartis (July 17, 2023)
- Lilly To Acquire Versanis To Improve Patient Outcomes In Cardiometabolic Diseases (July 14, 2023)
- Astellas Completes Acquisition Of Iveric Bio (July 11, 2023)
- Lilly To Acquire Dice Therapeutics To Advance Innovation In Immunology (June 20, 2023)
- Serb Pharmaceuticals Acquires Vistogard® And Xuriden® From Wellstat Therapeutics (July 13, 2023)
- Thermo Fisher Scientific To Acquire Corevitas (July 6, 2023)
Who to call at Veristat, and when
When Veristat changes hands, the new owners review vendors, systems and leadership. That is when the door opens.
- An alert the day Veristat raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Veristat, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Veristat. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Veristat makes an acquisition, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Frequently asked
Who acquired Scinopsis?
Scinopsis was acquired by Veristat, based in Southborough. The deal was reported on June 12, 2023. Veristat is privately held and operates in Biotechnology.
When did Veristat acquire Scinopsis?
Veristat's acquisition of Scinopsis was reported on June 12, 2023. Fundz records the date the transaction was first publicly reported, sourced from filings and company announcements.
What does Scinopsis do?
It is privately held, operating in Biotechnology.
This company was part of an acquisition. Fundz tracks who bought whom, and who to call on both sides.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.